Obesity Surgery

, Volume 15, Issue 8, pp 1161–1164

BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients

  • A Genco
  • T Bruni
  • S B Doldi
  • P Forestieri
  • M Marino
  • L Busetto
  • C Giardiello
  • L Angrisani
  • L Pecchioli
  • P Stornelli
  • F Puglisi
  • M Alkilani
  • A Nigri
  • N Di Lorenzo
  • F Furbetta
  • A Cascardo
  • M Cipriano
  • M Lorenzo
  • N Basso
Article

DOI: 10.1381/0960892055002202

Cite this article as:
Genco, A., Bruni, T., Doldi, S.B. et al. OBES SURG (2005) 15: 1161. doi:10.1381/0960892055002202

Background: The temporary use of the BioEnterics Intragastric Balloon (BIB) in morbidly obesity is increasing worldwide. The aim of this study is the evaluation of the efficacy of this device in a large population, in terms of weight loss and its influence on co-morbidities. Methods: Data were retrospectively recruited from the data-base of the Italian Collaborative Study Group for Lap-Band and BIB (GILB). After diagnostic endoscopy, the BIB was positioned and was filled with saline (500-700 ml) and methylene blue (10 ml). Patients were discharged with diet counselling (∼1000 Kcal) and medical therapy. The BIB was removed after 6 months. Positioning and removal were performed under conscious or unconscious sedation. Mortality, complications, BMI, %EWL, BMI loss and co-morbidities were evaluated. Results: From May 2000 to September 2004, 2,515 patients underwent BIB (722M/1,793F; mean age 38.9±14.7, range 12-71; mean BMI 44.4±7.8 kg/m2 ; range 28.0-79.1; and mean excess weight 59.5±29.8 kg, range 16-210). BIB positioning was uncomplicated in all but two cases (0.08%) with acute gastric dilation treated conservatively. Overall complication rate was 70/2,515 (2.8%). Gastric perforation occurred in 5 patients (0.19%), 4 of whom had undergone previous gastric surgery: 2 died and 2 were successfully treated by laparoscopic repair after balloon removal. 19 gastric obstructions (0.76%) presented in the first week after positioning and were successfully treated by balloon removal. Balloon rupture (n=9; 0.36%) was not prevalent within any particular period of BIB treatment, and was also treated by BIB removal. Esophagitis (n=32; 1.27%) and gastric ulcer (n=5; 0.2%) presented in patients without a history of peptic disease and were treated conservatively by drugs. Preoperative co-morbidities were diagnosed in 1,394/2,471 patients (56.4%); these resolved in 617/1,394 (44.3%), improved (less pharmacological dosage or shift to other therapies) in 625/1,394 (44.8%), and were unchanged in 152/1,394 (10.9%). After 6 months, mean BMI was 35.4±11.8 kg/m2 (range 24-73) and %EWL was 33.9±18.7 (range 0-87). BMI loss was 4.9±12.7 kg/m2 (range 0-25). Conclusions: BIB is an effective procedure with satisfactory weight loss and improvement in co-morbidities after 6 months. Previous gastric surgery is a contraindication to BIB placement.

OBESITYINTRAGASTRIC BALLOONWEIGHT LOSSCOMPLICATIONSCO-MORBIDITY

Copyright information

© Springer 2005

Authors and Affiliations

  • A Genco
    • T Bruni
      • S B Doldi
        • P Forestieri
          • M Marino
            • L Busetto
              • C Giardiello
                • L Angrisani
                  • L Pecchioli
                    • P Stornelli
                      • F Puglisi
                        • M Alkilani
                          • A Nigri
                            • N Di Lorenzo
                              • F Furbetta
                                • A Cascardo
                                  • M Cipriano
                                    • M Lorenzo
                                      • N Basso

                                        There are no affiliations available